Just out of left field.
We all know the phase III trials are going ahead now in Europe which is HUUUUUUUUUUUUUUUGGGGGEEEEE news.
Next stop clinical efficacy, product registration and sales.
Just wondering what the market might make of SEC approval for listing on the NASDAQ in a simultaneous announcement?
The SEC may have closed off on it at end of business Friday....
mega super double announcement on monday?
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.010(2.50%) |
Mkt cap ! $566.5M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.5¢ | 38.5¢ | $997.5K | 2.559M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 85852 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 75389 | 4 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |